Arthritis & Rheumatism, Volume 62,
November 2010 Abstract Supplement

Abstracts of the American College of
Rheumatology/Association of Rheumatology Health Professionals
Annual Scientific Meeting
Atlanta, Georgia November 6-11, 2010.


Costs for Health Care, Prescribed Drugs, and Sick Leave Differ for Patients with Different Types of Spondylarthropathy.

Bremander1,  Ann B. I., Turkiewicz2,  Aleksandra, Englund2,  Martin, Haglund3,  Emma, Kobelt2,  Gisela, Petersson2,  Ingemar F., Strombeck2,  Britta

Musculoskeletal Research Center, Dept. of Orthopedics, Clinical Sciences, Lund University, Lund, Research and Development Cente at Spenshult Hospital for Rheumatic Diseases, Oskarstrom, Sweden
Musculoskeletal Research Center, Dept. of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden
Musculoskeletal Research Center, Dept. of Orthopedics, Clinical Sciences, Lund University, Lund, Sweden, Research and Development Cente at Spenshult Hospital for Rheumatic Diseases, Halmstad, Sweden

Background:

The spondylarthropathy (SpA) group includes ankylosing spondylitis (AS), psoriatic arthritis (PsA), SpA associated with inflammatory bowel disease (IBD), undifferentiated SpA (USpA), and reactive arthritis (ReA). It has earlier been established that patients with AS have increased costs for health care and sick leave compared with the background population, but data for other types of SpA are scarce.

Objectives:

To estimate the costs for health care, prescribed drugs, and sick leave for the different SpA diagnoses.

Methods:

The Skåne Health Care Register (SHCR) in southern Sweden is a legislative, mandatory register based on physicians ICD-10 diagnoses and covers all in- and outpatient health care (total population 1.2 million). We identified all subjects having received a diagnosis of SpA during the years 2003–2007. To increase specificity we required all cases to be diagnosed at least once by a rheumatologist/internist or having had at least two clinic visits with the diagnosis by any other physician. Costs due to health care consumption, prescribed drugs and sick leave were retrieved from the SHCR, the Prescribed Drug Register, and the Swedish Social Insurance Agency for the years 2006–2007, including all patients 15 to 65 years of age.

Results:

3 561 patients with SpA (1 758 men and 1 803 women), mean age (SD) 47 (12) years were identified. The IBD patients had the highest costs for health care (mean [euro]8 057, SD [euro]10 545), prescribed drugs (mean [euro]4 360, SD [euro]6 610), and sick leave (mean [euro] 11 570, SD [euro]10 415) whereas PsA patients had the lowest cost for health care ([euro]4 757, SD [euro]7 080) but the second highest for prescribed drugs (mean [euro]2 986, SD [euro]6 391) and sick leave (mean [euro] 9 224, SD [euro]11 222) (Table).

Table. Cost is Euro (e) for health care, prescribed drugs, and sick leave per patient with Spondylarthropathy (SpA) over 2 years.

 NAge Mean (SD)Sex Men/WomenCost for health care Mean (SD) Median (range)Cost for prescribed drugs Mean (SD) Median (range)Cost for sick leave Mean (SD) Median (range)
All SpA3.56147 (12)1.758/18035.234 (9.350)2.557 (5.917)8.542 (11.130)
    2.510 (0–158.830)178 (0–58244)1188 (0–47595)
AS79348 (11)532/2615547 (9765)2872 (6021)9191 (11535)
    2627 (0–140359)187 (0–38587)1751 (0–47.595)
PsA1.57849 (12)704/8744757 (70)2986 (6.391)9.224 (11.222)
    2.477 (0–77.428)301 (0–58.244)1.974 (0–455)
IBD8449 (11)24/608.057 (10.545)4.360 (6.610)11.570 (10.415)
    4.079 (263–58.057)1.251 (0–25.761)10.837 (0–36851)
USpA61344 (11)251/3625.371 (9.120)2.018 (5.511)7.740 (10.827)
    2.445 (0–83.805)97 (0–45.449)503 (0–42.145)
ReA49343 (14)247/2465.604 (12.436)1.044 (3.871)5.791 (10.108)
    2.346 (0–158.831)23 (0–53.395)0 (0–39.348)

Conclusion:

The different clinical forms of SpA are also seen as different cost patterns for health care, prescribed drugs, and sick leave due to disease consequences and treatment traditions.

To cite this abstract, please use the following information:
Bremander, Ann B. I., Turkiewicz, Aleksandra, Englund, Martin, Haglund, Emma, Kobelt, Gisela, Petersson, Ingemar F., et al; Costs for Health Care, Prescribed Drugs, and Sick Leave Differ for Patients with Different Types of Spondylarthropathy. [abstract]. Arthritis Rheum 2010;62 Suppl 10 :761
DOI: 10.1002/art.28529

Abstract Supplement

Meeting Menu

2010 ACR/ARHP